What I have: a GLP-1 receptor agonist · five days.
I can predict the outcome but I cannot explain it, which means I will get the next case wrong.
I would like to know how confident the field actually is about this.
Can someone derive this rather than assert it?
Moving the day by 5 stretches one interval from 7 days to 12 — one interval, and then it is over. At a seven-day half-life the trough at the end of a normal week sits at 50 per cent of the preceding peak. At the end of a 12-day week it sits at 0.5^(12÷7) = 30.5 per cent: a fall of 19.5 percentage points, once, after which every interval is 7 days again. That is the entire pharmacokinetic content of the change. Whether 19.5 points of trough is worth anything is a question about your own tolerability curve rather than about the molecule. Shortening is the asymmetric direction: moving 5 days earlier makes that interval 2 days and raises the trough to 82 per cent instead of lowering it, and accumulation is the failure mode that goes with that one. Timing changes are made under supervision; nothing here is medical advice.
The honest answer is that a single missed weekly dose is not an event, and that two in a row starts to matter.
For a daily agent with a thirteen-hour half-life, a missed dose is a much larger proportional loss. The usual approach is to skip it and take the next scheduled one rather than doubling.
Set a recurring reminder tied to something you already do weekly. The commonest cause of a missed dose is not forgetting the drug but losing track of the day.
Loss of tolerance during a treatment gap is documented and is the basis for re-titration after an interruption.
Within about five days for a weekly agent, take it. Beyond that, skip and resume.
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemThe relevant arithmetic is that one missed dose of a weekly agent produces a trough about half the usual, which is well inside the normal range.
With a one-week half-life dosed weekly, missing one dose means exposure falls by about half over the following week — the same trough you would reach if you simply extended the interval. That is well within the range the agent operates in.
If more than two consecutive weekly doses are missed, tolerance to the gastrointestinal effects begins to fade and re-titration from a lower step becomes the sensible approach.
Set a recurring reminder attached to something you already do weekly.
The short version: for a weekly agent, take it if you are within a few days; if you are close to the next scheduled dose, skip it and resume.
The published guidance for the weekly agents is broadly: if the missed dose is remembered within about five days, take it and continue on the usual day; if more than five days have passed, skip it and take the next scheduled dose.
Never take two doses close together to compensate. The peak exposure is roughly doubled, and gastrointestinal tolerability tracks peak exposure closely.
Peak exposure rather than average exposure drives gastrointestinal tolerability, which is the reason doubling up is advised against.
Never double up. Peak exposure is what drives the symptoms.
The part that matters: changing the regular dosing day is possible and should be done by moving forward, not by squeezing two doses together.
One missed dose is not a reason to change the schedule or the dose. Two or more is a reason to consider where you are restarting from.
Published missed-dose guidance for the weekly agents in this class specifies a window of about five days, derived directly from the half-life.
Two or more missed weekly doses means considering a lower restarting step.
edited 20 Sept 2025 by u100_marks — added the method parameters
Start with the interval since the missed dose, because that single number determines the answer.
To change your regular dosing day, move the next dose later rather than earlier, keeping at least three days between doses for a weekly agent. Moving earlier compresses the interval and raises exposure.
Half-lives across the class span roughly thirteen hours to one week, which is why the answer is agent-specific.
A published missed-dose window applies to a licensed product with a known content, which unverified material is not.
To move your dosing day, move it later and keep three days between doses.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.